{{Rsnum
|rsid=6837793
|Chromosome=4
|position=163335583
|Orientation=plus
|GMAF=0.1148
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=NPY1R
|Gene_s=NPY1R
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 18.6 | 80.5
| HCB | 0.0 | 2.9 | 97.1
| JPT | 0.0 | 1.8 | 98.2
| YRI | 12.9 | 44.2 | 42.9
| ASW | 3.5 | 36.8 | 59.6
| CHB | 0.0 | 2.9 | 97.1
| CHD | 0.0 | 1.8 | 98.2
| GIH | 0.0 | 15.8 | 84.2
| LWK | 8.2 | 46.4 | 45.5
| MEX | 0.0 | 10.5 | 89.5
| MKK | 5.8 | 35.3 | 59.0
| TSI | 1.0 | 21.6 | 77.5
| HapMapRevision=28
}}[[rs6837793]] is a SNP associated with the NPY5 receptor gene, located in the single promoter region likely to be co-regulating the Y1 and Y5 receptor genes.

In a study of 101 mostly Caucasian patients prescribed the atypical antipsychotic [[risperidone]], carriers of a [[rs6837793]](G) allele were more likely to gain significant weight compared to [[rs6837793]](A;A) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, [[rs8179183]] and [[rs705381]], were also significantly associated with weight profiles in these patients.{{PMID|17199131}}

{{PMID Auto
|PMID=18254975
|Title=Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.
|OA=1
}}

{{PMID Auto
|PMID=18828811
|Title=Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}